These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 9443926

  • 21. Negative regulation of opioid receptor-G protein-Ca2+ channel pathway by the nootropic nefiracetam.
    Yoshii M, Furukawa T, Ogihara Y, Watabe S, Shiotani T, Ishikawa Y, Nishimura M, Nukada T.
    Ann N Y Acad Sci; 2004 Oct; 1025():389-97. PubMed ID: 15542741
    [Abstract] [Full Text] [Related]

  • 22. Nefiracetam activation of CaM kinase II and protein kinase C mediated by NMDA and metabotropic glutamate receptors in olfactory bulbectomized mice.
    Moriguchi S, Han F, Shioda N, Yamamoto Y, Nakajima T, Nakagawasai O, Tadano T, Yeh JZ, Narahashi T, Fukunaga K.
    J Neurochem; 2009 Jul; 110(1):170-81. PubMed ID: 19457128
    [Abstract] [Full Text] [Related]

  • 23. Potentiation of N-methyl-D-aspartate-induced currents by the nootropic drug nefiracetam in rat cortical neurons.
    Moriguchi S, Marszalec W, Zhao X, Yeh JZ, Narahashi T.
    J Pharmacol Exp Ther; 2003 Oct; 307(1):160-7. PubMed ID: 12805478
    [Abstract] [Full Text] [Related]

  • 24. Long-lasting enhancement of ACh receptor currents by lysophospholipids.
    Ikeuchi Y, Nishizaki T, Matsuoka T, Sumikawa K.
    Brain Res Mol Brain Res; 1997 May; 45(2):317-20. PubMed ID: 9149106
    [Abstract] [Full Text] [Related]

  • 25. CaM kinase II and protein kinase C activations mediate enhancement of long-term potentiation by nefiracetam in the rat hippocampal CA1 region.
    Moriguchi S, Shioda N, Han F, Narahashi T, Fukunaga K.
    J Neurochem; 2008 Aug; 106(3):1092-103. PubMed ID: 18445137
    [Abstract] [Full Text] [Related]

  • 26. A possible mechanism for improvement by a cognition-enhancer nefiracetam of spatial memory function and cAMP-mediated signal transduction system in sustained cerebral ischaemia in rats.
    Takeo S, Niimura M, Miyake-Takagi K, Nagakura A, Fukatsu T, Ando T, Takagi N, Tanonaka K, Hara J.
    Br J Pharmacol; 2003 Feb; 138(4):642-54. PubMed ID: 12598418
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Role of phosphorylation in desensitization of acetylcholine receptors expressed in Xenopus oocytes.
    Hoffman PW, Ravindran A, Huganir RL.
    J Neurosci; 1994 Jul; 14(7):4185-95. PubMed ID: 8027770
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Regulation of HERG potassium channel activation by protein kinase C independent of direct phosphorylation of the channel protein.
    Thomas D, Zhang W, Wu K, Wimmer AB, Gut B, Wendt-Nordahl G, Kathöfer S, Kreye VA, Katus HA, Schoels W, Kiehn J, Karle CA.
    Cardiovasc Res; 2003 Jul 01; 59(1):14-26. PubMed ID: 12829172
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Dual bradykinin B2 receptor signalling in A431 human epidermoid carcinoma cells: activation of protein kinase C is counteracted by a GS-mediated stimulation of the cyclic AMP pathway.
    Liebmann C, Graness A, Ludwig B, Adomeit A, Boehmer A, Boehmer FD, Nürnberg B, Wetzker R.
    Biochem J; 1996 Jan 01; 313 ( Pt 1)(Pt 1):109-18. PubMed ID: 8546671
    [Abstract] [Full Text] [Related]

  • 35. Cellular mechanisms underlying cognition-enhancing actions of nefiracetam (DM-9384).
    Yoshii M, Watabe S, Sakurai T, Shiotani T.
    Behav Brain Res; 1997 Feb 01; 83(1-2):185-8. PubMed ID: 9062681
    [Abstract] [Full Text] [Related]

  • 36. Additive effect of ADP and CGRP in modulation of the acetylcholine receptor channel in Xenopus embryonic myocytes.
    Liou JC, Fu WM.
    Br J Pharmacol; 1995 Jun 01; 115(4):563-8. PubMed ID: 7582473
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Improvement of depressive behaviors by nefiracetam is associated with activation of CaM kinases in olfactory bulbectomized mice.
    Han F, Nakano T, Yamamoto Y, Shioda N, Lu YM, Fukunaga K.
    Brain Res; 2009 Apr 10; 1265():205-14. PubMed ID: 19233146
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.